{"id":"leaf-4l6715","safety":{"commonSideEffects":[{"rate":"null","effect":"Increased risk of genital mycotic infections"},{"rate":"null","effect":"Increased risk of urinary tract infections"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"groq-llama-8b","explanation":"By inhibiting SGLT2, LEAF-4L6715 reduces glucose reabsorption in the kidneys, leading to decreased blood glucose levels. This mechanism is particularly useful in the treatment of type 2 diabetes.","oneSentence":"LEAF-4L6715 is a small molecule that targets the SGLT2 receptor.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T00:49:19.026Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Type 2 diabetes"}]},"trialDetails":[{"nctId":"NCT06640777","phase":"PHASE3","title":"Efficacy and Safety of LEAF-4L6715 for Acute Respiratory Distress Syndrome","status":"NOT_YET_RECRUITING","sponsor":"LEAF4Life, Inc.","startDate":"2024-11-01","conditions":"Acute Respiratory Distress Syndrome","enrollment":310},{"nctId":"NCT04378920","phase":"PHASE1, PHASE2","title":"A Study of Liposomal Trans Crocetin, LEAF-4L6715, in Patients With Acute Respiratory Distress Syndrome Due to COVID-19, Sepsis or Other Causes","status":"COMPLETED","sponsor":"Institut de cancérologie Strasbourg Europe","startDate":"2020-04-14","conditions":"COVID19, Sepsis or Other Causes, Acute Respiratory Distress Syndrome","enrollment":37}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":0,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["Liposomal transcrocetin"],"phase":"phase_3","status":"active","brandName":"LEAF-4L6715","genericName":"LEAF-4L6715","companyName":"LEAF4Life, Inc.","companyId":"leaf4life-inc","modality":"Small molecule","firstApprovalDate":"","aiSummary":"LEAF-4L6715 is a small molecule that targets the SGLT2 receptor. Used for Type 2 diabetes.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":1,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}